RetractedArticleBioengineered2022

Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K/Akt signaling pathway.

Qi Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.